Dear Healthcare Professional!
A1C:
ADA Goal: <7%. Performed: Each 3 or 6 months
GlycoMark:
Ref Range: ≥10 µg/mL. Performed: With A1C, 2-weeks post-treatment modifications, when control is questionable
Glucose:
ADA Goal: <180 mg/dL. Performed: (Ideally) Daily, and 2 hours postmeal
References:
1Erlinger TP, Brancati FL. Diabetes Care. 2001 Oct;24(10):1734-8.
2Bonora E, et al. Diabetologia. 2006 May;49(5):846-54.
3Hirsch IB, et al. Diabetes Technol Ther. 2012 Nov;14(11):973-83; quiz 983.
4Dungan KM. Expert Rev Mol Diagn. 2008 Jan;8(1):9-19.
5American Diabetes Association. Medical Management of Type 2 Diabetes, 7th edition. 2012.
6Selvin E, et al. Clin Chem. 2014 Nov; 60(11): 1409–1418.
7Selvin E, et al. Diabetes 2016;65:201–208.
8Lee AK, et al. Diabetes Care 2017 Dec; 40(12): 1661-1667.
9Rawlings AM, et al. Diabetes Care 2017 Jul; 40(7): 879-886.
10Nowak N, et al. Diabetologia 2013 Apr; 56(4): 709–713.
11Erbach M, et al. J Diabetes Sci Technol. 2016;10:1161-1168.
12Klonoff DC, et al. J Diabetes Sci Technol. 2011;5:1529-1548.
The information contained herein is not medical, diagnostic or treatment advice for any particular patient. Physicians should use their clinical judgment and experience when deciding how to diagnose and treat patients and in the use of the GlycoMark test in the treatment of the patient. Please refer to the GlycoMark product insert for more information.